Qlife Holding AB (FRA:4HG0) Margin of Safety % (DCF FCF Based): N/A (As of Jul. 01, 2026)


FRA:4HG0 Qlife Holding AB FRA:4HG0
25 GF Score
Price €0.15
GF Value €0.06
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Qlife Holding AB Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Qlife Holding AB's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

FRA:4HG0 vs ABT, SYK, MDT: Margin of Safety % (DCF FCF Based) Comparison

For the Medical Devices subindustry, Qlife Holding AB's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Qlife Holding AB Margin of Safety % (DCF FCF Based) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Qlife Holding AB's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Qlife Holding AB's Margin of Safety % (DCF FCF Based) falls into.


FRA:4HG0
25GF Score
Qlife Holding AB FRA:4HG0
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Qlife Holding AB (FRA:4HG0) Overvalued in 2026?

Based on GuruFocus' analysis, Qlife Holding AB stock appears to be overvalued. The current stock price of €0.15 is trading 156.7% above its estimated GF Value™ of €0.06. GuruFocus considers Qlife Holding AB to be Significantly Overvalued.

Key valuation signals for FRA:4HG0:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: €0.06 vs. price of €0.15 (156.7% above fair value)
  • GF Score™: 25/100 with 9 warning signs

No single metric tells the full story. See the FRA:4HG0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Qlife Holding AB Business Description

Other Exchanges QLIFE:Sweden
Address Nellikevagen 22, Goteborg, SWE, SE-412 63
Qlife Holding AB is a medical device company that seeks to revolutionize the clinical biomarker testing of whole blood by taking it out of the lab and into the homes of the people who needs it. The Egoo Home System is an integrated platform consisting of a small home device and disposable capsules, each of which tests for a specific biomarker. It provides a digital infrastructure for sharing the data with the patient's doctor, clinic or hospital via smartphone and computer.
25GF Score

Get the complete analysis for FRA:4HG0

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.15
Price
€0.06
GF Value